104 related articles for article (PubMed ID: 20044868)
21. Increased depression and metabolic risk in postmenopausal breast cancer survivors.
Serra MC; Goldberg AP; Ryan AS
Diabetol Metab Syndr; 2016; 8():44. PubMed ID: 27453736
[TBL] [Abstract][Full Text] [Related]
22. Incidence of metabolic syndrome in breast cancer survivors on adjuvant hormonal therapy.
Kate A; Kadambari D
J Pharmacol Pharmacother; 2016; 7(1):28-30. PubMed ID: 27127393
[No Abstract] [Full Text] [Related]
23. C-Reactive Protein and Breast Cancer: New Insights from Old Molecule.
Asegaonkar SB; Asegaonkar BN; Takalkar UV; Advani S; Thorat AP
Int J Breast Cancer; 2015; 2015():145647. PubMed ID: 26693355
[TBL] [Abstract][Full Text] [Related]
24. Single subject design: Use of time series analyses in a small cohort to understand adherence with a prescribed fluid restriction.
Reilly CM; Higgins M; Smith A; Culler SD; Dunbar SB
Appl Nurs Res; 2015 Nov; 28(4):356-65. PubMed ID: 26608439
[TBL] [Abstract][Full Text] [Related]
25. Increased cardiovascular risk factors in breast cancer survivors identified by routine measurements of body composition, resting heart rate and arterial blood pressure.
Jones DH; Nestore M; Henophy S; Cousin J; Comtois AS
Springerplus; 2014; 3():150. PubMed ID: 24790808
[TBL] [Abstract][Full Text] [Related]
26. Metabolic syndrome in Mexican women survivors of breast cancer: a pilot study at a general hospital.
Ortiz-Mendoza CM; de-la-Fuente-Vera TA; Pérez-Chávez E
Med Arch; 2014; 68(1):19-21. PubMed ID: 24783905
[TBL] [Abstract][Full Text] [Related]
27. Randomized controlled trial to evaluate the effects of combined progressive exercise on metabolic syndrome in breast cancer survivors: rationale, design, and methods.
Dieli-Conwright CM; Mortimer JE; Schroeder ET; Courneya K; Demark-Wahnefried W; Buchanan TA; Tripathy D; Bernstein L
BMC Cancer; 2014 Apr; 14():238. PubMed ID: 24708832
[TBL] [Abstract][Full Text] [Related]
28. Exercise after diagnosis and metabolic syndrome among breast cancer survivors: a report from the Shanghai Breast Cancer Survival Study.
Bao PP; Zheng Y; Nechuta S; Gu K; Cai H; Peng P; Shu XO; Lu W
Cancer Causes Control; 2013 Sep; 24(9):1747-56. PubMed ID: 23860950
[TBL] [Abstract][Full Text] [Related]
29. The presentation of metabolic dysfunction and the relationship with energy output in breast cancer survivors: a cross-sectional study.
Guinan EM; Connolly EM; Kennedy MJ; Hussey J
Nutr J; 2013 Jul; 12():99. PubMed ID: 23855321
[TBL] [Abstract][Full Text] [Related]
30. The effect of aerobic exercise on metabolic and inflammatory markers in breast cancer survivors--a pilot study.
Guinan E; Hussey J; Broderick JM; Lithander FE; O'Donnell D; Kennedy MJ; Connolly EM
Support Care Cancer; 2013 Jul; 21(7):1983-92. PubMed ID: 23430010
[TBL] [Abstract][Full Text] [Related]
31. Body composition changes in females treated for breast cancer: a review of the evidence.
Sheean PM; Hoskins K; Stolley M
Breast Cancer Res Treat; 2012 Oct; 135(3):663-80. PubMed ID: 22903689
[TBL] [Abstract][Full Text] [Related]
32. Lifestyle interventions for cardiovascular risk reduction in women with breast cancer.
Knobf MT; Coviello J
Curr Cardiol Rev; 2011 Nov; 7(4):250-7. PubMed ID: 22758626
[TBL] [Abstract][Full Text] [Related]
33. Psychosocial intervention effects on adaptation, disease course and biobehavioral processes in cancer.
Antoni MH
Brain Behav Immun; 2013 Mar; 30 Suppl(Suppl):S88-98. PubMed ID: 22627072
[TBL] [Abstract][Full Text] [Related]
34. Strength training stops bone loss and builds muscle in postmenopausal breast cancer survivors: a randomized, controlled trial.
Winters-Stone KM; Dobek J; Nail L; Bennett JA; Leo MC; Naik A; Schwartz A
Breast Cancer Res Treat; 2011 Jun; 127(2):447-56. PubMed ID: 21424279
[TBL] [Abstract][Full Text] [Related]
35. Intervening on the side effects of hormone-dependent cancer treatment: the role of strength training.
Hanson ED; Hurley BF
J Aging Res; 2011 Jan; 2011():903291. PubMed ID: 21318049
[TBL] [Abstract][Full Text] [Related]
36. Metabolic syndrome and elevated C-reactive protein in breast cancer survivors on adjuvant hormone therapy.
Thomson CA; Thompson PA; Wright-Bea J; Nardi E; Frey GR; Stopeck A
J Womens Health (Larchmt); 2009 Dec; 18(12):2041-7. PubMed ID: 20044868
[TBL] [Abstract][Full Text] [Related]
37. An observational study to examine changes in metabolic syndrome components in patients with breast cancer receiving neoadjuvant or adjuvant chemotherapy.
Dieli-Conwright CM; Wong L; Waliany S; Bernstein L; Salehian B; Mortimer JE
Cancer; 2016 Sep; 122(17):2646-53. PubMed ID: 27219902
[TBL] [Abstract][Full Text] [Related]
38. Risk of metabolic syndrome in postmenopausal breast cancer survivors.
Buttros Dde A; Nahas EA; Vespoli Hde L; Uemura G; de Almeida Bda R; Nahas-Neto J
Menopause; 2013 Apr; 20(4):448-54. PubMed ID: 23149866
[TBL] [Abstract][Full Text] [Related]
39. [Metabolic syndrome in postmenopausal breast cancer survivors].
Nahas EA; de Almeida Bda R; Buttros Dde A; Véspoli Hde L; Uemura G; Nahas-Neto J
Rev Bras Ginecol Obstet; 2012 Dec; 34(12):555-62. PubMed ID: 23329285
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
